Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Pilot Projects in Aging

University of Alberta

$50,000.00

Aging and damage post reperfused infarction

FY 2008-09

Summary
A 'heart attack' means sudden blockage of a coronary artery. It cuts off blood supply causing injury, with damage to heart muscle cells and the matrix that supports the cells. Healing repairs the damaged area by a fibrotic scar and spared muscle increases in bulk over several weeks by a process of 'remodeling'. With extensive damage, the dead area undergoes marked thinning, stretching, bulging and ballooning, thereby changing heart shape and size. The deformed heart cannot pump blood well and the heart enlarges. Chamber enlargement itself damages the supporting matrix, causing more enlargement. A vicious cycle is set up; the heart gets bigger, the pump weaker, the victims cannot breathe or move around easily, and many die. There are not enough hearts for transplants. The best way to prevent the 'bad remodeling' is to restore blood supply; this is called reperfusion. It is best done early to save muscle. However, reperfusion also causes more muscle cell and matrix damage, resulting in 'stunning' whereby the heart does not contract well and even chamber enlargement. Heart attacks are common in the elderly who do not do so well even after reperfusion. Aging may accelerate the progression to damage or increase damage after reperfusion. Some novel proteins may modify the muscle cell and matrix damage after reperfusion and could be targeted in the elderly. Some drugs may also reduce the muscle cell and matrix damage after reperfusion, thereby preventing bad remodeling, death and disability. These proteins and drugs need to be studied in live large animal models of aging and both genders before application in elderly human patients.
Program
Catalyst Grant: Pilot Projects in Aging
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
181830
Name
Jugdutt Bodh I
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
Aging and damage post reperfused infarction
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging
Keyworddelim
Aging; Function; Healing Myocardial Infarction; Matrix Proteins; Remodeling; Reperfusion
Abstract
A 'heart attack' means sudden blockage of a coronary artery. It cuts off blood supply causing injury, with damage to heart muscle cells and the matrix that supports the cells. Healing repairs the damaged area by a fibrotic scar and spared muscle increases in bulk over several weeks by a process of 'remodeling'. With extensive damage, the dead area undergoes marked thinning, stretching, bulging and ballooning, thereby changing heart shape and size. The deformed heart cannot pump blood well and the heart enlarges. Chamber enlargement itself damages the supporting matrix, causing more enlargement. A vicious cycle is set up; the heart gets bigger, the pump weaker, the victims cannot breathe or move around easily, and many die. There are not enough hearts for transplants. The best way to prevent the 'bad remodeling' is to restore blood supply; this is called reperfusion. It is best done early to save muscle. However, reperfusion also causes more muscle cell and matrix damage, resulting in 'stunning' whereby the heart does not contract well and even chamber enlargement. Heart attacks are common in the elderly who do not do so well even after reperfusion. Aging may accelerate the progression to damage or increase damage after reperfusion. Some novel proteins may modify the muscle cell and matrix damage after reperfusion and could be targeted in the elderly. Some drugs may also reduce the muscle cell and matrix damage after reperfusion, thereby preventing bad remodeling, death and disability. These proteins and drugs need to be studied in live large animal models of aging and both genders before application in elderly human patients.
Competitiondate
200903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jugdutt, Bodh I
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $50,000~ $0~